Nature Medicine · 2018 · 855 citations · 30 references
MedicineImmunologyOncologyImmunotherapyMetastasisTumor ImmunologyAdjuvant ImmunotherapyCancer ImmunotherapyCheckpoint Inhibitor TherapyCombination ImmunotherapyNeoadjuvant ImmunotherapyNeoadjuvant TherapyMelanoma Adjuvant TherapyMelanoma ImmunotherapyMelanoma Neoadjuvant TherapyNeoadjuvant Checkpoint InhibitionNeoadjuvant Immune Checkpoint Blockade
30
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley et al. · Nature · 2014 · 6.6K citations · Full text
Life Sciences, Immunology, Pathology +14
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 2009 · 4.6K citations · Full text
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers, Jared Lunceford, Michael Nebozhyn et al. · Journal of Clinical Investigation · 2017 · 3.9K citations · Full text
Medicine, Immunology, Oncology +17